Invest in Celularity. Inc. on Stash
Celularity Inc., is a clinical-stage cellular medicine company developing off-the-shelf allogeneictherapies derived from the postpartum human placenta.
Ticker: CELU
Celularity. Inc.
$1.79
-11.39%
$
CELU Performance Breakdown
Share Price
$1.79
Today's change
-1.11%
Year to date change (YTD)
-18.64%
Dividend yield
0.0
Last dividend paid
N/A
Last dividend pay date
N/A
About CELU
Celularity Inc., is a clinical-stage cellular medicine company developing off-the-shelf allogeneictherapies derived from the postpartum human placenta.
Celularity. Inc. Stock Ticker
CELU
For more information
Invest in Celularity. Inc. on Stash
Celularity Inc., is a clinical-stage cellular medicine company developing off-the-shelf allogeneictherapies derived from the postpartum human placenta.
Certain companies are volatile
Certain companies can be volatile, meaning the stock price fluctuates significantly. Don’t put all your eggs into one basket and remember to keep the Stash Way in mind when you invest.
Celularity. Inc. stock news
Why invest with Stash?
Fractional shares
Thousands of stocks and ETFs. No investing minimums.
Unlimited trades
Plus no add-on trading commission fees.†
Diversification analysis
Custom investment recommendations can help you diversify.
Automatic investing
Dividend reinvestment,8 recurring investments, and more.
The Stock-Back® Card
We’ll give you matching stock in companies you shop at.1
Learn how to invest
Get professional advice and education at every step.
How to buy Celularity. Inc. stock on Stash
Stash allows you to purchase smaller, more affordable pieces of investments (called fractional shares) rather than the whole share, which can be significantly more expensive.
Stash offers two subscription plans: Stash Growth and Stash+.
Once your market order of Celularity. Inc. stock is complete, you'll officially be a shareholder of Celularity. Inc.!
Invest in Celularity. Inc. on Stash
Celularity Inc., is a clinical-stage cellular medicine company developing off-the-shelf allogeneictherapies derived from the postpartum human placenta.



